Apex Orthopedics Welcomes David Elliott as Senior VP
Apex Orthopedics Investments LLC is thrilled to announce a significant addition to its leadership team with the appointment of David Elliott as Senior Vice President of Business Development. Elliott brings a wealth of experience and expertise in business strategy, capital raising, and investor relations.
David's Responsibilities and Impact
In his role at Apex Orthopedics, David will focus on raising capital for the company’s portfolio operations, ensuring the firm maintains its trajectory for growth. His extensive background highlights a consistent record of successful business development, underpinned by his solid experience across various financial sectors.
Capital Raising Successes
David Elliott's accomplishments are notable, having secured a $150 million credit facility during his tenure with a private equity firm and a $50 million facility for a prominent NFL team owner. Furthermore, he managed to raise an impressive $900 million from investors throughout his eight years at Titan Advisors. These experiences have shaped his solid foundation in financial strategy and investor engagement, key components that Apex Orthopedics is eager to harness.
Leadership Perspectives
Christopher E. Banas, President and CEO of Apex Orthopedics Investments, expressed enthusiasm for David's arrival, stating, "We are excited to welcome David to our team. His vast experience will be pivotal in driving our portfolio companies' growth and securing vital investments.'
Banas emphasized that David's ability to forge robust relationships with investors is a crucial asset that would align perfectly with Apex Orthopedics' mission.
Previous Experience and Background
Before his transition to Apex Orthopedics, David held key leadership positions in alternative investments and private banking. These roles underscored his capability to navigate complex financial landscapes and create strategies that deliver significant outcomes for stakeholders.
Vision for Apex Orthopedics
David shared his enthusiasm about joining the company, saying, "I'm looking forward to leveraging my experience at Apex Orthopedics to foster growth and innovativeness across our portfolio. The discussions I've had with Christopher and the team have left me inspired by the company’s mission and its unwavering commitment to quality and innovation."
About Apex Orthopedics Investments LLC
Apex Orthopedics Investments LLC is an asset management firm founded by a team of distinguished professionals including Christopher Banas, CEO; Murray Penner, MD, FRCSC, Chairman; Greg Berlet, MD, FRCSC, FAOA, FAAOS, Chief Medical Officer; and Stephen Brigido, DPM, FACFAS, Chief Innovation Officer. The company specializes in developing advanced orthopedic devices, particularly for foot and ankle applications. Their focus areas include fixation hardware, midfoot arthrodesis, midfoot arthroplasty, and advanced solutions for Achilles repair.
With a commitment to revolutionizing patient care, Apex is on a mission to empower orthopedic professionals by providing innovative and effective solutions. Leveraging their extensive experience in product development, the team has successfully launched over 200 products that have generated combined revenues exceeding USD 3 billion.
Frequently Asked Questions
Who is David Elliott?
David Elliott has recently been appointed as the Senior Vice President of Business Development at Apex Orthopedics Investments LLC.
What are David's main responsibilities at Apex Orthopedics?
David is tasked with raising capital for the company's portfolio companies and managing investor relationships to drive growth.
What experience does David Elliott bring to Apex?
David has over 30 years of experience in business development and has a successful track record in capital raising across various sectors.
What is the mission of Apex Orthopedics Investments?
Apex aims to develop innovative orthopedic solutions focused on patient care while empowering professionals in the field.
How has Apex Orthopedics performed in product development?
The company has launched over 200 products that have collectively generated more than USD 3 billion in revenue, showcasing their impact on the orthopedic device industry.
